Literature DB >> 16189196

Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term.

Valentina Brusati1, Maciej Józwik, Marcin Józwik, Cecilia Teng, Cinzia Paolini, Anna Maria Marconi, Frederick C Battaglia.   

Abstract

The objective of the present investigation was to determine fetal and maternal plasma concentrations of nonglucose carbohydrates and polyols in normal human pregnancies at term. Uncomplicated human pregnancies (n = 50) were studied at > or =37 wk gestation. Blood samples were obtained from umbilical artery, umbilical vein, and maternal peripheral blood at the time of elective cesarean section. Plasma concentrations of inositol, glycerol, erythritol, sorbitol, and mannose were determined by HPLC analysis. Differences between umbilical venous, umbilical arterial, and maternal concentration were tested by the two-tailed t test for paired samples. Correlations between umbilical and maternal concentration and between umbilical venoarterial concentration difference and umbilical arterial concentration were assessed by Pearson's correlation and multiple regression analysis. All newborns were appropriate for gestational age, and oxygenation and acid-base balance were within the normal range for all fetuses studied. For most of the polyols (inositol, sorbitol, and erythritol), the fetal concentration was significantly higher than the maternal concentration. The umbilical venoarterial concentration difference for inositol was -10.5 +/- 3.6 microM, for glycerol was 10 +/- 1.7 microM, for sorbitol was 3.8 +/- 0.5 microM (p < 0.001), and for mannose was 7.6 +/- 0.7 microM. There was a significant correlation between maternal concentration and umbilical venous concentration of mannose (UV(MAN) = 15.38 + 0.69 M(MAN); R(2) = 0.46; p < 0.001). These results indicate that in normal human pregnancies at term, inositol is produced by the fetus, sorbitol is produced by the placenta, and there is a significant umbilical uptake of mannose from the maternal circulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189196     DOI: 10.1203/01.PDR.0000180549.86614.73

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  Sugar substitutes during pregnancy.

Authors:  Eliza Pope; Gideon Koren; Pina Bozzo
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

2.  Placental TonEBP/NFAT5 osmolyte regulation in an ovine model of intrauterine growth restriction.

Authors:  Juan A Arroyo; Pastora Garcia-Jones; Amanda Graham; Cecilia C Teng; Frederick C Battaglia; Henry L Galan
Journal:  Biol Reprod       Date:  2012-03-30       Impact factor: 4.285

3.  Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes.

Authors:  Barton C Staat; Henry L Galan; Jeri E F Harwood; Gene Lee; Anna Maria Marconi; Cinzia L Paolini; Alex Cheung; Frederick C Battaglia
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

Review 4.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

5.  Determination of the NFAT5/TonEBP transcription factor in the human and ovine placenta.

Authors:  Juan A Arroyo; Cecilia Teng; Frederick C Battaglia; Henry L Galan
Journal:  Syst Biol Reprod Med       Date:  2009-08       Impact factor: 3.061

Review 6.  Mechanisms for the establishment and maintenance of pregnancy: synergies from scientific collaborations.

Authors:  Fuller W Bazer; Robert C Burghardt; Gregory A Johnson; Thomas E Spencer; Guoyao Wu
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

7.  Cocaine is pharmacologically active in the nonhuman primate fetal brain.

Authors:  Helene Benveniste; Joanna S Fowler; William D Rooney; Bruce A Scharf; W Walter Backus; Igor Izrailtyan; Gitte M Knudsen; Steen G Hasselbalch; Nora D Volkow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.

Authors:  Laura D Brown; Alex Cheung; Jeri E F Harwood; Frederick C Battaglia
Journal:  J Nutr       Date:  2009-06-03       Impact factor: 4.798

9.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Authors:  Dale L Phelps; Robert M Ward; Rick L Williams; Kristi L Watterberg; Abbot R Laptook; Lisa A Wrage; Tracy L Nolen; Timothy R Fennell; Richard A Ehrenkranz; Brenda B Poindexter; C Michael Cotten; Mikko K Hallman; Ivan D Frantz; Roger G Faix; Kristin M Zaterka-Baxter; Abhik Das; M Bethany Ball; T Michael O'Shea; Conra Backstrom Lacy; Michele C Walsh; Seetha Shankaran; Pablo J Sánchez; Edward F Bell; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2013-09-04       Impact factor: 3.756

10.  Plasma concentrations of carbohydrates and sugar alcohols in term newborns after milk feeding.

Authors:  Laura D Brown; Claudio Cavalli; Jeri E F Harwood; Annachiara Casadei; Cecilia C Teng; Cristina Traggiai; Giovanni Serra; Giulio Bevilacqua; Frederick C Battaglia
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.